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SUMMARY
Age is a major risk factor in age-related macular
degeneration (AMD), but the underlying cause is un-
known. We find increased Rho-associated kinase
(ROCK) signaling and M2 characteristics in eyes of
aged mice, revealing immune changes in aging.
ROCK isoforms determine macrophage polarization
into M1 and M2 subtypes. M2-like macrophages
accumulated in AMD, but not in normal eyes, sug-
gesting that these macrophages may be linked to
macular degeneration. M2 macrophages injected
into the mouse eye exacerbated choroidal neovas-
cular lesions, while M1 macrophages ameliorated
them, supporting a causal role for macrophage sub-
types in AMD. Selective ROCK2 inhibition with a
small molecule decreased M2-like macrophages
and choroidal neovascularization. ROCK2 inhibition
upregulated M1 markers without affecting macro-
phage recruitment, underlining the plasticity of these
macrophages. These results reveal age-induced in-
nate immune imbalance as underlying AMD patho-
genesis. Targeting macrophage plasticity opens up
new possibilities for more effective AMD treatment.
INTRODUCTION
Age-related macular degeneration (AMD) is the leading cause
of adult vision loss in the developed countries. AMD has two
types, the dry form that ultimately leads to macular atrophy
and the more rapidly progressing wet form, characterized
by choroidal neovascularization (CNV) and leakage. Most
AMD cases are of the dry atrophy type, which can become
exudative due to CNV. The normal choroid maintains quies-
cence through an excess of antiangiogenic versus proangio-
genic factors. Little is known about what might reverse that
balance and lead to an angiogenic switch. While aging is the
strongest risk factor for AMD (Klein et al., 2002), how age in-
fluences pathogenesis is unknown. Current drug therapy in
AMD is based on repeated intravitreal injections of vascular
endothelial growth factor A (VEGF-A) inhibitors, which only
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reduce symptoms. A recent study showed macular atrophy in
virtually all long-term anti-VEGF-A-treated AMD cases, one
third of which suffered alarming visual decay (Rofagha et al.,
2013).
Macrophages are found in AMD lesions (Tsutsumi et al.,
2003); however, their detailed role in the disease is not under-
stood. Plasticity and diversity are fundamental characteristics
of macrophages (Sica and Mantovani, 2012). Undifferentiated
M0 macrophages can polarize into classical proinflammatory
M1-like and alternative anti-inflammatory M2-like macro-
phages, two extremes in a continuum of polarization states
(Sica and Mantovani, 2012). A mixture of polarization pheno-
types coexist, which reflect the highly dynamic and complex
tissue conditions. Furthermore, polarized macrophages show
a high level of plasticity in response to tissue signals. There-
fore, elucidation of the mechanisms and molecules involved
in macrophage polarization and plasticity may provide thera-
peutic avenues. Both M1- and M2-like subtypes are found
in AMD (Cao et al., 2011); however, their roles in the patho-
genesis have not been studied. Interleukin-1b (IL-1b), IL-12,
IL-23, interferon-g (IFN), lipopolysaccharine (LPS), and tumor
necrosis factor-a (TNF-a) induce the M1-like phenotype that
expresses CCL3, CCL5, CD80, CCR7, and inducible nitric
oxide synthase (iNOS). In contrast, IL-4, IL-10, IL-13, and
TGF-b promote the M2-like phenotype that expresses
CCL22, CD206, CD163, Ym 1, Fizz 1, and arginase 1 (Manto-
vani et al., 2004).
Rho-associated, coiled-coil-containing protein kinases
(ROCKs) are involved in cytoskeletal rearrangement, contractility
(Riento and Ridley, 2003), angiogenesis, and inflammation (Arita
et al., 2009). RhoA and RhoE are upstream of ROCK, which has
two isoforms, ROCK1 and ROCK2, whose intracellular localiza-
tions differ depending on the type and condition of the examined
cells (Chun et al., 2012). The role of ROCK isoforms in macro-
phage polarization and AMD is completely unexplored. ROCK
substrates include myosin light chain (MLC), myosin binding
subunit of myosin phosphatase (MYPT), and ezrin/radixin/moe-
sin (ERM) proteins, while downstream targets include inhibitor
of kappaB alpha (IkB-a) and nuclear factor-kB (NF-kB) (Cam-
marano and Minden, 2001).
Here we uncover a molecular switch for macrophage polariza-
tion through the ROCK signaling pathway. We show an M2-type
shift with aging and establish the causal role of M2-like macro-
phages in CNV pathology.
RESULTS
Choroidal Neovascular Endothelium Expresses ROCK
To determine whether ROCK1 and ROCK2 are expressed in hu-
man AMD, surgically excised CNV membranes from AMD pa-
tients were used for immunohistochemistry. In these samples,
we stained for both ROCK isoforms and for the von Willebrand
Factor (vWF). Surgically excised CNV membranes from human
AMD (n = 7) and idiopathic macular degeneration (n = 7) patients
expressed high levels of both ROCK1 and ROCK2. In contrast,
the retinal specimens from normal patients showed significantly
less staining for either isoform (n = 5). Analogously, in the laser-
induced CNV in mouse and monkey, ROCK1 and ROCK2 co-
localized in angiogenic endothelium, but were expressed far
less in normal vessels (Figure 1).
Increased ROCK Signaling in Choroidal
Neovascularization
To investigate ROCK signaling in CNV, we performed western
blots for ROCK isoforms and its substrate, MYPT1, in laser-
induced CNV tissues in mice. MYPT1 phosphorylation peaked
at 3 and 7 days following laser injury in the mouse choroid, while
ROCK1 and ROCK2 expressions remained unchanged through-
out the course of CNV. To block ROCK2 activity, we used a novel
selective inhibitor (Figures S1 and S2). Dual ROCK1/2 and selec-
tive ROCK2 inhibition reduced pMYPT1 to normal unlasered
levels (Figure 2A).
MLC phosphorylation was increased in CNV and reduced to
normal levels with dual ROCK1/2 and selective ROCK2 inhibi-
tion. Upstream of ROCK, RhoA was significantly increased in
CNV, while RhoE was unchanged. Dual ROCK1/2 and selective
ROCK2 inhibition reduced RhoA expression in lasered eyes to
those found in unlasered controls (Figure 2B). This could suggest
a feedback loop for ROCK activity in regulating RhoA.
ROCK2 Inhibition Reduces Choroidal
Neovascularization and Leakage
To investigate the role of ROCK in CNV, we inducedCNVby laser
injury and treated the mice with the dual ROCK1/2 inhibitor,
fasudil, or the selective ROCK2 inhibitor and quantified lesion
size and vascular leakage. CNV lesions were 60% smaller
with dual ROCK1/2 inhibition compared with control. Selective
ROCK2 inhibition significantly reduced CNV in a dose-depen-
dent fashion, 66% reduction at 1mg/kg, while maximum efficacy
was reached at 10 mg/kg. In comparison, the CNV size in
ROCK1+/Tie1Cre mice that have reduced endothelial
ROCK1, did not differ from that of lasered Tie1Cre or WT control
(Figure 2C).
Dual ROCK1/2 and selective ROCK2 inhibition suppressed the
percentage of the clinically relevant grade IV leakage (Figure 2D).
In comparison, ROCK1+/TieCre showed the same amount of
leakage as laseredWTmice (Figure 2E). Furthermore, intravitreal
injections of fasudil in monkeys significantly reduced the per-
centage of grade IV leakages, as well as CNV membrane thick-
ness (Figure 2F).
Endothelial NF-kB Not Required for CNV Formation
To study downstream mediators of ROCK, we measured IkB-a
and pIkB-a in the eyes of normal and lasered mice with and
without inhibitor treatments. IkB-a phosphorylation peaked
3 days after laser injury, while higher levels of NF-kB and phos-
phorylated NF-kB p65 (RelA) were detected by day 3 through
14 (Figure 3A). NF-kB protein expression was higher in CNV,
possibly due to leukocyte accumulation. Dual ROCK1/2 and se-
lective ROCK2 inhibition reduced CNV-induced NF-kB protein
expression, as well as IkB-a and NFkB phosphorylations to
levels found in unlasered eyes. The IkB-a protein expression
was not affected by laser injury or the various treatments (Fig-
ure 3B). While our results are in line with the fact that IkB-a is
downstream of ROCK, IkB-a can also be phosphorylated by
other kinases.
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NF-kB contributes to angiogenesis (Tabruyn and Griffioen,
2008), but its role in CNV is not understood. In the Tie1DN
mouse, which lacks endothelial NF-kB signaling (Henke et al.,
2007), CNV and leakage were the same as that in lasered WT
or in the Tie1Cre control mice. However, ROCK2 inhibition in
the Tie1DNmice significantly reduced CNV (Figures 3C and 3D).
ROCK Mediated Macrophage Infiltration in Choroidal
Neovascularization
Macrophage recruitment in mice peaks 3 days after laser injury
(Tsutsumi et al., 2003). The number of accumulated F4/80(+)
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Figure 1. CNV Lesions Express Both ROCK
Isoforms
Double immunostaining shows localizations of
vWF (green) and ROCK1 or ROCK2 (red) in ocular
tissues from normal retina-choroidal complexes
and human AMD membranes, laser-induced CNV
in monkey and in mice. In the CNV tissues of all
three species, nonendothelial cells also expressed
ROCK isoforms. Blue indicates nuclei stained with
4,6-diamidino-2-phenylindole (DAPI). The scale
bar represents low magnification at 100 mm and
high magnification at 20 mm.
macrophages in WT mice at day 3 was
significantly reduced by dual ROCK1/2,
but not by selective ROCK2 inhibition
(Figure 4A). Lasered CD18/ mice
showed levels of F4/80(+) cells compara-
ble to that of unlasered WT mice, indi-
cating that the increased accumulation
is due to recruitment.
In laser-induced CNV in monkey eyes,
intravitreal fasudil injection significantly
reduced macrophage infiltration (Fig-
ure 4B). Immunohistochemistry showed
staining for both ROCK1 and ROCK2
isoforms in infiltrated macrophages in
the CNV lesions of mouse and monkey,
but not in normal control eyes (Figure 4C).
To investigate the differential impacts
of dual ROCK1/2 versus ROCK2 inhibi-
tion on leukocyte transmigration from
angiogenic vessels, we developed a
new imaging technique (Figure S3). The
combination of growth-factor-induced
corneal angiogenesis with in vivo acridine
orange (AO) labeling of leukocytes al-
lowed visualization of leukocyte extra-
vasation from normal and angiogenic
vessels in a chemotactic gradient. In
MCP-1 implanted corneas, dual ROCK1/
2 inhibition suppressed leukocyte trans-
migration, while selective ROCK2 inhibi-
tion did not (Figure 4D). This is supported
by our finding that dual ROCK1/2 inhibi-
tion or ROCK1 knockdown affects cyto-
skeletal proteins, while selective ROCK2 inhibition or ROCK2
knockdown does not (Figure S4).
ROCK Mediated Macrophage Polarization in Choroidal
Neovascularization
The role of ROCK isoforms in macrophage polarization has
previously not been investigated. In surgically excised mem-
branes from AMD patients, ROCK1 and ROCK2 co-localized
with CD206, expressed on M2 macrophages (Figure 5A).
CD80(+) cells expressed ROCK1 and ROCK2 in neovascular
tissues from AMD patients, whereas normal eyes did not stain
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for CD80, CD206, or significant staining for neither ROCK
isoform.
The time course of protein expression showed elevated IL-4
and CD163 levels in CNV through day 7 or day 14, respectively.
CCR7 was unchanged, while CD80 wasmoderately higher in the
first 3 days. Further, CCR3 that was previously reported to be
higher in CNV (Takeda et al., 2009) remained unchanged at the
examined time points (Figure 5B).
To characterize the kinetics of macrophage accumulation, we
performed flow cytometry in normal and lasered mouse eyes
during CNV development. The number of CD11b(+)CD80(+)
M1-like macrophages increased on day 1 after laser injury and
remained high through day 7. In the CNV model, angiogenesis
starts 3 days after laser injury and peaks on day 7 (Ishibashi
et al., 1987). We found a peak of CD11b()CD206(+) cells on
day 2 after laser injury, which preceded the reported start
of angiogenesis. On days 3 through 7, the percentage of
CD11b(+)CD206(+) cells increased with a peak on day 7, coin-
ciding with the maximum angiogenic response in the laser-injury
model (Figure 5C). These data show that even though both
A
C
D
B
E F
Figure 2. CNV Depends on ROCK Signaling
ROCK signaling was quantified in experimentally induced CNV and the effect of ROCK inhibition was studied in vivo.
(A and B) Western blot analysis (A) using whole-cell lysates from choroids of normal and CNV eyes at the indicated time points after laser injury. Vehicle and
inhibitor-treated CNV eyes were screened at day 7 for anti-pMYPT1, anti-MYPT1, anti-ROCK1, anti-ROCK2, as well as (B) anti-RhoA, anti-RhoE, and anti-pMLC
Abs, n = 3.
(C) Representative mouse CNV lesions treated with vehicle, fasudil (n = 5, 40 lesions), ROCK2 inhibitor at different concentrations (n = 4, 32 lesions in each group)
and in ROCK1+/TieCre mouse (n = 5, 40 lesions) with the corresponding quantifications. Red dashed line shows the extent of the laser-induced CNV lesions
filled with FITC-dextran in flat-mounted choroids. Scale bar represents 100 mm.
(D and E) Leakage from the angiogenic vessels (D) was visualized by FA and quantified in early-phase (1–2 min) and late-phase (6–8 min) angiograms of Brown
Norway rats treated with vehicle, fasudil, or ROCK2 inhibitor, as well as (E) in ROCK1+/TieCre mice. Yellow dashed circle shows the extent of the CNV lesions
filled with fluorescein; yellow arrow indicates the optic nerve. The scale bar represents 1 mm. The percentage of lesions is graded as I, II, III, defined as no to
moderate leakage, and IV, clinically relevant leakage (n = 4, 32 lesions).
(F) Fluorescent angiography in monkey and CNV thickness measurements with vehicle or fasudil treatment (n = 4). *p < 0.05; **p < 0.01. Error bars are SEM.
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macrophage subtypes are found in CNV development, the accu-
mulation kinetics of the M2-like macrophages closely matches
the angiogenic response.
Dual ROCK1/2 and ROCK2 inhibition substantially decreased
the CD11b(+)CD206(+) M2-like population when examined on
day 7. The CD11b(+)CD206() cell population was reduced by
dual ROCK1/2 inhibition but not by ROCK2 inhibition (Figure 5D).
ROCK Regulates Macrophage Polarization
To investigate the role of ROCK signaling in macrophage polar-
ization, we stained for each isoform in macrophages (Fig-
ure 6A). In undifferentiated M0 macrophages ROCK1 and
ROCK2 were evenly distributed in the cytoplasm. In M1 macro-
phages, ROCK1 was concentrated in the perinuclear re-
gions. In comparison, ROCK2 was distributed in the cytoplasm.
The cytoplasmic distribution of ROCK2 in M1 macrophages
showed unique circular areas of nonexpression reminiscent
of vacuoles. In M2 macrophages, ROCK1 was evenly distrib-
uted in the cytoplasm, while ROCK2 was highly concentrated
near the nucleus.
To elucidate the role of ROCK in macrophage fate, we used
genetic knockdown and pharmacological inhibition (Figure 6B).
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Figure 3. Lack of Endothelial NFk-B Signaling Does Not Affect CNV
(A) Western blot analysis in whole-cell lysates of lasered eye extracts at different time points after laser injury.
(B) Representative western blot of anti-pIkB-a, anti-IkB-a, anti-pNF-kB p65, anti-NF-kB, anti-GAPDH with fasudil (20 mg/kg), Y-27632 (10 mg/kg), or ROCK2
inhibitor (10 mg/kg) treatment in choroids with CNV (day 7) with the corresponding quantifications.
(C) Representative micrographs of CNV lesions (day 7) in choroidal flat mounts from C57BL/6J, TieCre, or Tie-1-DNmice with or without ROCK2 inhibition. Scale
bar represents 100 mm and quantitative analysis of CNV volume (n = 5 animals in each group, 40 lesions). *p < 0.05; **p < 0.01.
(D) Representative early phase (1–2 min) and late-phase (6–8 min) fluorescein angiograms in C57BL/6J and Tie-1-DN mice and quantification. Scale bar rep-
resents 1 mm. Error bars are SEM.
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In M0 cells, ROCK2 knockdown increased CCL3, while ROCK1
knockdown increased CCL22. In an M1 environment, ROCK2
inhibition decreased IL-10 secretion, while it increased CCL5.
In an M2 environment, ROCK1 knockdown increased CCL22
secretion. Both dual ROCK1/2 and selective ROCK2 inhibition
reduced IL-10 secretion. Furthermore, dual ROCK1/2 and selec-
tive ROCK2 inhibition reduced the percentage of CD206(+) cells
in flow cytometry, while ROCK2 inhibition increased the percent-
age of CD80(+) cells.
In bonemarrow-derivedM2macrophages, dual ROCK1/2 and
selective ROCK2 inhibition reduced Fizz 1 and Ym 1. In compar-
ison, only ROCK2 inhibition but not dual ROCK1/2 inhibition
reduced arginase 1. In contrast, ROCK2 inhibition significantly
increased iNOS expression in RT-PCR. These data indicate a
previously unknown regulatory role for ROCK isoforms in macro-
phage polarization (Figure 6C).
Pharmacologic inhibition of ROCK or knockdown of ROCK
isoforms did not affect VEGF-A expression (Figure S5).
Causal Role of M2 Macrophages in Choroidal
Neovascularization
To examine the contribution of macrophage subtypes in CNV
formation, we differentiated murine bone marrow-derived mac-
rophages into M1 or M2 phenotype (Figure S6) and injected
them into the vitreous of laser-treated WT mice. While undiffer-
entiated macrophages did not affect CNV, M2 macrophages
increased the lesion size, not however in ROCK2 inhibitor-
treated animals. In comparison, M1 macrophages reduced
CNV lesions. Intravitreal injection of M1 macrophages in lasered
mice that were treated with the ROCK2 inhibitor did not reduce
lesion size any further, indicating that the beneficial effect of
ROCK2 inhibition in vivo is indeed throughmacrophage polariza-
tion (Figure 7A).
Next, WT animals were intravitreally injected with M1 (INF-g
and LPS) or M2 (IL-4, IL-10, and IL-13) transforming cytokine
cocktails. Intravitreal injection of INF-g and LPS reduced CNV
size and leakage. CNV and leakage in the M1-cytokine cocktail
injected eyes remained unaffected when the animals were in
addition ROCK2 inhibitor treated.
In contrast, intravitreal injection of IL-4, IL-10, and IL-13
increased CNV size and the percentage of clinically relevant
IV leakage, which were reduced to control levels when
the animals were in addition ROCK2 inhibitor treated (Fig-
ures 7B and 7C). These results indicate the importance
of the cytokine profile in CNV, mediated through ROCK
signaling.
M2-skewed IL-12p40/ mice showed larger CNV lesions
than WT animals. In contrast, M1-skewed adiponectin/ mice
had smaller CNV lesions than WT. These results show that an
endogenous bias for macrophage subtypes affects CNV.
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Figure 4. ROCK-Mediated Regulation of Inflammatory Leukocyte Infiltration during CNV
(A) Representative micrographs of laser-induced CNV lesions, immunostained for F4/80 in C57BL/6J mice treated with vehicle, fasudil, or ROCK2 inhibitor or in
CD18/ mice and quantification of the number of F4/80-positive macrophages in CNV lesions (n = 3 animals in each group). In each eye, six lesions were
placed. From each lesion, ten or more sections were stained, the results of which were averaged for each lesion/animal. Scale bar represents 100 mm.
(B) Impact of fasudil on macrophage infiltration in laser-induced CNV in monkey (n = 4). This shows representative micrographs of CNV lesions, immunostained
for CD68 in lasered monkeys treated with vehicle or fasudil and quantification of the number of CD68-positive leukocytes in CNV lesions (n = 4). **p < 0.01. Scale
bar represents 100 mm.
(C) Double immunostaining of laser-induced CNV in monkey and mice with Abs of ROCK1 or ROCK2 and CD68 or F4/80. GCL, ganglion cell layer; INL, inner
nuclear layer; ONL, outer nuclear layer; RPE, retinal pigmented epithelial layer; C, choroid. Scale bar represents 50 mm
(D) Ex vivo imaging of impact of ROCK inhibitors on MCP-1-mediated leukocyte transmigration. AO(+) leukocytes and Con A(+) angiogenic vessels in MCP-1-
implanted corneas, 2 hr after AO injection, 24 hr after pellet implantation with vehicle, fasudil, Y-27632, or ROCK2 inhibitor treatment. This shows quantification of
the number of AO(+) leukocytes in areas of MCP-1-implanted corneas 2 hr after AO injection, 24 hr after pellet implantation; n = 4; *p < 0.05, **p < 0.01. Error bars
are SEM.
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While ROCK2 inhibition significantly reduced CNV size in IL-
12p40/ mice, it did not do the same in adiponectin/ mice
(Figure 7D). The efficacy of ROCK2 inhibition in IL-12p40/
mice and the lack of it in adiponectin/ mice further support
the finding that the beneficial effects of ROCK2 inhibition are
through a shift in macrophage polarization.
Figure 5. Polarization of Ocular Infiltrating Macrophages by ROCK
(A) Double immunostaining of normal human retina-choroidal complex and AMD membranes with Abs against CD206 or CD80 (green) and ROCK1 or ROCK2
(red) (n = 4). Overview bar represents 50 mm; high magnification, 20 mm.
(B) Western blot analysis with anti-IL-4, anti-CD163, anti-CCR3, anti-CCR7, anti-CD80 or anti-b-tubulin Abs, using whole-cell lysates from lasered mouse
choroids at the indicated time points after injury. Other proteins from the same experiment shown in Figure 2A.
(C) FACS analysis of infiltrating cells from untreated and laser-injured choroids at the different time points after laser injury. Cells were stained for CD11b, CD80,
and CD206. The percentages of infiltrating CD11b(+)CD206(+), CD11b(+)CD80(+), CD11b()CD206(+), CD11b()CD80(+) cells in CNV are shown at the indicated
times (n = 6).
(D) FACS analysis of infiltrating cells from CNV eyes (choroid) with vehicle, fasudil, or ROCK2 inhibitor treatment at day 7 with PE-CD11b mAb and FITC-CD206
mAb. The percentages of infiltrating CD11b(+)CD206(+) cells and CD11b(+)CD206() cells in CNV are shown with the treatment at day 7 (n = 6). *p < 0.05;
**p < 0.01. Error bars are SEM.
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Figure 6. Isoform-Specific Inhibition of ROCK Determines Macrophage Fate
(A) Cellular localization of ROCK isoforms in polarized macrophages (M0, M1, M2). RAW 264.7 cells were differentiated into M0, M1, and M2 by cytokine
treatment and used for immunostaining with Abs against ROCK1 or ROCK2 (red), b-tubulin (green) and DAPI (blue). Arrowheads, vacuoles. Scale bar represents
10 mm. In a small number of M1 cells, ROCK2 was also found more concentrated around the nucleus.
(B) ROCK isoforms were blocked in RAW 264.7, U937, and BMDM cells in M0, M1, or M2 environments. Chemokines, cell markers, and genes were quantified by
luminex, flow cytometry, or RT-PCR. Data represent average from three or more independent experiments. RT-PCR data were evaluated after subtraction of the
specific endogenous control gene expression (18S rRNA). *p < 0.05; **p < 0.01. Error bars indicate SEM.
(C) Schematic overview of how ROCK signaling impacts polarization.
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Age Compounded ROCK Signaling and an M2 Shift
To investigate ROCK signaling as a function of age, we quanti-
fied ROCK isoforms, their downstream mediators, and macro-
phage markers in the choroids of young (8- to 12-week-old)
and aged (>16-month-old) WTmice with and without laser injury.
Compared with the baseline in the normal young, MYPT1- and
IkB-a phosphorylation were higher in the lasered young and in
the normal-aged animals, with the highest levels found in the
aged lasered animals, suggesting a compounding effect of
age. In comparison, MYPT1 and IkB-a protein expressions did
not differ between the groups (Figure 7E).
IL-4 was elevated in the young WT animals with CNV
compared with the base levels in the normal young eyes. Unla-
sered agedWTmice had higher IL-4 levels compared with young
WT animals even with CNV. Interestingly, the highest IL-4 level
was found in the unlasered aged animals. CD163 was exclu-
sively increased in CNV, while it was not affected by age in the
normal eyes. The M1-specific markers CCR7 and CD80 were
at similar levels in young and aged animals with or without laser
injury (Figure 7E). However, in contrast to prior report (Takeda
et al., 2009), CCR3 protein was unchanged in the eyes with
CNV (Figure S7).
The higher levels of IL-4 in CNV were reversed by dual
ROCK1/2 or selective ROCK2 inhibition. ROCK2 inhibition but
not dual ROCK1/2 inhibition increased the M1 markers CD80
and CCR7 in lasered eyes (Figure 7F).
DISCUSSION
We introduce ROCK signaling as amaster switch in macrophage
polarization and suggest that M2-like macular-degeneration-
associated macrophages (MaDAMs) are a cause of disease.
Paradoxically, macrophages have been reported to promote
CNV (Tsutsumi et al., 2003) and also to inhibit CNV (Apte et al.,
2006), without elucidating which macrophage subtypes might
be involved. Our work resolves this apparent discrepancy and il-
luminates how macrophages can both decrease and increase
CNV, depending on their phenotype. When injected into the
vitreal cavity, M1-like macrophages reduced while M2-like mac-
rophages increased CNV. While both cell types were found
in laser-injured mouse choroids, the accumulation kinetics of
M2-like macrophages match the angiogenic response. Smaller
CNV lesions in M1-skewed adiponectin/ mice, in contrast
to the larger lesions in the M2-skewed IL-12p40/ mice,
further bolstered the key role for macrophage polarization in
CNV. ROCK2 inhibition suppressed M2 and furthered M1 polar-
ization while ROCK1 inhibition furthered M2 polarization.
In mouse, monkey, and human, ROCK expression and sig-
naling were associated with CNV. In human AMD membranes,
angiogenic but not normal vessels expressed ROCK iso-
forms, making them candidate biomarker. Phosphorylation of
downstream mediators of ROCK—MLC, MYPT1, IkB-a, and
NF-kB p65—was increased in CNV and suppressed with dual
ROCK1/2 or selective ROCK2 inhibition, indicating a key role
for this pathway in CNV. NF-kB protein expression was higher
in CNV, possibly due to immune cell accumulation. While we
excluded a role for endothelial NF-kB in CNV, NF-kB activity
in immune cells could be decisive in AMD. Dual ROCK1/2 and
selective ROCK2 inhibition significantly reduced CNV, albeit
through different mechanisms. We found ROCK1 signaling to
be required for macrophage extravasation, while ROCK2 inhibi-
tion did not affect recruitment. Upstream of ROCK, RhoA was
increased in CNV and reduced to normal levels with ROCK
inhibition.
MaDAMs accumulate in AMD, possibly due to changes in
the chorioretinal microenvironment with age. A potential cause
could be IL-4, which we found increased with age. ROCK2 inhi-
bition reduced IL-4 to baseline levels in CNV, thereby affecting
the cytokine microenvironment in which macrophages differen-
tiate in addition to directly shifting the macrophage balance
from M2 to M1. Interestingly, IL-4 was reported to suppress
laser-induced CNV through release of soluble Flt-1 from macro-
phages (Wu et al., Association for Research in Vision and
Ophthalmology, 2011), pointing out the potential of macrophage
polarization and plasticity as therapeutic targets.
Analogous to tumor-associated macrophages (TAMs) that
correlate with poor prognosis in cancer, MaDAMs could predict
onset or severity of AMD, for instance if quantified by molecular
imaging (Sun et al., 2014) or in the peripheral blood. Specifically,
CD163 was only found in CNV, which could become a biomarker
for exudative AMD. MaDAMs expressed both ROCK isoforms,
and ROCK2 inhibition reduced their number in CNV without
affecting total macrophage numbers. Selective ROCK2 but not
dual ROCK1/2 inhibition increased M1 markers, CD80 and
CCR7. This preserves the beneficial macrophages that are
essential for retinal health (London et al., 2011) and simulta-
neously restores the balance between proangiogenic MaDAMs
and their angiostatic counterparts.
Age increased ROCK signaling and the M2-type immune
response, evidenced by elevated pMYPT1, pIkB-a, CCR3, and
IL-4 in the choroids of senescent mice. In contrast, age did not
affect the M1-type response. This establishes a novel link be-
tween age and macrophage polarization that could explain the
angiogenic switch in AMD. In contrast to prior work, in which
IL-10-treated macrophages failed to reduce CNV (Kelly et al.,
2007), our results showed that M2-differentiated macrophages
significantly increase CNV. Importantly, the mechanism shown
in this work is distinct from the prior concept of differential
recruitment of macrophage subtypes in CNV (Zhao et al., 2013)
since ROCK2 does not affect macrophage recruitment.
Demand is high for a ROCK2-specific inhibitor (Riento and
Ridley, 2003). This study introduces an orally available selective
ROCK2 inhibitor, which lacks toxicity in human. The antagonistic
role of ROCK isoforms in macrophage polarization suggests that
more efficacy and fewer side effects are possible with isoform-
specific inhibition. A benefit of selective ROCK2 inhibition
compared with dual ROCK1/2 inhibition is the M1 upregulation
in lesions since selective ROCK2 inhibition does not interfere
withmacrophage recruitment. Instead, by targetingmacrophage
plasticity, selective ROCK2 inhibition restores the immunological
balance that prevails in the normal young eye. Compared with
anti-VEGF-A agents that only treat late symptoms (Rofagha
et al., 2013), targeting macrophage polarization addresses roots
of the disease.
AMD is considered an inflammatory disease (Hollyfield et al.,
2008), yet our results highlight its immune-modulatory nature.
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We found elevated NF-kB signaling in CNV that was suppressed
with ROCK inhibition. NF-kB can be proangiogenic or antiangio-
genic (Aurora et al., 2010). Since CNV was independent of endo-
thelial NF-kB activity, yet pIkB-a was higher in aging and CNV, it
is feasible that NF-kB’s contribution to CNV is in immune cells.
The causal role of macrophage polarization in CNV challenges
the paradigm that AMD is inflammatory. Instead, rather than a
sole phenotypic signature or a cell type, our results point toward
immune imbalance as a root of AMD. These insights together
with the considerable plasticity of macrophages open new pros-
pects for immune-based therapy in age-related diseases. While
macrophage polarization is a promising target, the complexity of
the subject matter requires future insights to be fully understood.
This study introduces the role of ROCK in macrophage polar-
ization. Aging increases ROCK2 signaling, resulting in overt
expression of the proangiogenic MaDAMs. This newly revealed
chain of events explains the angiogenic switch in the aging
eye. In contrast, a shift of the fundus microenvironment toward
M1, i.e., through selective ROCK2 inhibition, reduces the pathol-
ogy and restores the physiological macrophage balance found
in the young. These results facilitate the development of bio-
markers for AMD and new immune-based therapies.
EXPERIMENTAL PROCEDURES
Human Tissues
Human CNV membranes were surgically excised from AMD and idiopathic
neovascular maculopathy patients. The symptoms were documented as
classic CNV, subfoveal or juxtafoveal CNV with hemorrhage and retinal
detachment, when present. The average age for AMD patients (n = 7) was
71.3 years and for idiopathic neovascular maculopathy (n = 7) was 33.2 years.
The average duration from the time of onset to surgery was 8.9 months. The
average size of the CNV lesions was 0.84 of the disc diameter. Control eyes
were from donor eyes without AMD. An institutional review board granted
approval for allocation and histological analysis of specimens.
Animals
All animal experiments adhered to The Guiding Principles in the Care and Use
of Animals (DHEW Publication, NIH 80-23).
Monkeys
Eyes from cynomolgus monkeys between 3 and 4 years of age were used in
this study. General anesthesia was achieved by intramuscular injection of ke-
tamine hydrochloride (20 mg/kg; Sankyo Yell Pharmaceutical Products).
Rodents
Male C57BL/6J mice (Stock# 000664; Jackson Laboratory) weighing 24–28 g
were used. Jackson Laboratory tested and confirmed that their C57BL/6J pro-
duction line is free of the rd8mutation. In addition, we tested the rd8 status of
our experimental mice by PCR, the results of which showed that our experi-
mental strains were free of the rd8 mutation in the Crb1 gene (Mattapallil
et al., 2012) (Figure S8). The genetically modified mice used in this work
were phenotypically normal and on C57BL/6J background. They did not differ
in weight or age from their WT counter parts. Animals were sheltered in venti-
lated plastic cages in a temperature-controlled animal facility with a 12-hr light/
dark cycle and were fed standard laboratory chow and water ad libitum. In this
study, young WT were 8–12 weeks old, while aged animals were >16 months
old. Male, 8- to 12-week-old adiponectin/ and IL-12p40/ mice were
purchased from Jackson Laboratory. Adiponectin regulates M2 polarization
and adiponectin/mice express more M1 cells (Ohashi et al., 2010). Macro-
phages from IL-12p40/mice have a bias toward theM2 phenotype (Bastos
et al., 2002).
Tie1Cre/IkB-aDN (Tie1DN) Mice. For this project, the IkB-aDN (loxP-DN)
mice were crossed with the Tie1Cre mice to generate the Tie1Cre/IkB-aDN
mice (or short Tie1DN) that were used for CNV experiments. As a result of the
IkB-aDN expression in the endothelial cells, these mice lack NF-kB signaling
in their vascular endothelium. Noteworthy, Tie-1-Cre mice do not express
Cre only in the vascular endothelial cells. There was a 12%–20% Cre expres-
sion in adult erythroid, myeloid, and lymphoid cells (Gustafsson et al., 2001).
The IkB-aDNmice are knock-in mice. In brief, the cDNA of the human NF-kB
suppressor IkB-aDN was integrated by homologous recombination in frame
into the b-catenin locus (Schmidt-Ullrich et al., 2001). In the floxed IkB-aDN
mice that were used in the current work, a loxP-stop-loxP cassette was cloned
in front of the transgene, resulting in the human IkB-aDN suppressor only to be
expressed in the presence of Cre (Freund et al., 2005; Henke et al., 2007;
Schmidt-Ullrich et al., 2001). IkB-aDN was expressed in all tissues, consistent
with the ubiquitous distribution of b-catenin.
The ROCK1+/Tie1Cre Mice. To have ROCK1-deficient mice on a pig-
mented background, we generated tissue-specific haploinsufficient ROCK1-
deficient mice on C57Bl/6J background. For this, Tie1-Cre ROCK1 LoxP/
(or endothelial-specific ROCK1-deficient mice) were generated by mating
Tie1-Cre recombinase knock-in mice with ROCK1 LoxP/ mice (Huang
et al., 2012). Heterozygote ROCK1+/ mice on C57Bl/6J background are
viable and fertile with no obvious phenotypic abnormalities. They express
ROCK1 in approximately half the amount of normal WT, while there is no
compensatory upregulation of ROCK2 (Rikitake et al., 2005).
Cell Culture and Transfection
The monocyte cell line U937 (CRL-1593.2; ATCC) was maintained in RPMI-
1640 supplemented with 10% fetal bovine serum (FBS) (Atlanta Biologicals),
glutamine (2 mmol/L), penicillin (100 U/ml), and streptomycin (100 mg/ml;
GIBCO, BRL). The mouse monocyte cell line RAW 264.7 (TIB-71; ATCC) was
maintained in DMEM (30-2002; ATCC).
Transfections were performed using control (sc-37007), ROCK1 (sc-
29473h, sc-36432 m), and ROCK2 (sc-29474h, sc-36433 m) siRNA from
Santa Cruz Biotechnology via electroporation (VCA-1004 Amaxa).
Differentiation of Bone-Marrow-Derived Macrophages
Bonemarrow cells were collected from femurs and tibias of WTC57Bl/6Jmice.
The cells were cultured in RPMI1640 medium supplemented with 20% FCS,
Figure 7. Age-Induced ROCK Signaling and M2 Differentiation Cause CNV
(A) Representative laser-induced CNV results from mice after intravitreal injections of vehicle, M0, M1, or M2 macrophages with or without ROCK2 inhibitor and
the corresponding quantifications (n = 5 mice, 10 eyes). Scale bar represents 100 mm.
(B) Representative micrographs of CNV lesions from mice after intravitreal cytokine injections, M1 cocktail: INF-g and LPS, M2 cocktail: IL-4, Il-10, IL13 and the
corresponding quantifications. Scale bar represents 100 mm.
(C) Leakage from the angiogenic vessels was visualized by FA and quantified in early-phase (1–2 min) and late-phase (6–8 min) angiograms of mice injected with
either M1 or M2 cocktail. Scale bar represents 1 mm.
(D) Representative micrographs of CNV lesions from C57BL/6J mice, IL-12p40/ and adiponectin/ mice with and without ROCK2 inhibitor and the cor-
responding quantifications. Scale bar represents 100 mm.
(E) Representative western blots of normal and CNV (day 3) choroids from young (8–12 weeks old) and aged (>16 months old) WT mice with the corresponding
quantifications; n = 3, *p < 0.05; **p < 0.01.
(F) Representative western blots of anti-IL-4, anti-CD80, and anti-CCR7 with fasudil (20 mg/kg), Y-27632 (10mg/kg), or ROCK2 inhibitor (10 mg/kg) treatments in
choroids with CNV (day 7) with the corresponding quantifications. Error bars are SEM.
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30% L cell sup (containing M-CSF) and P/S for 5 days. Bone marrow-derived
macrophages (BMDMs) were stimulated with 1 mg/ml LPS and 20 ng/ml IFN-
g (M1 phenotype) or 20 ng/ml IL-4, IL-10, and IL-13 (M2 phenotype) for 24 hr.
BMDMs were collected and washed with PBS/2 mM EDTA (cold), incubated
with 5mg/ml anti-FcgR mAb (2.4G2), followed by staining with 2.5 mg/ml
CD80-FITC, CD206-FITC, or isotype control. After washing with PBS/EDTA,
BMDMs were analyzed using a flow cytometer (FACS Calibur).
Immunohistochemistry
Paraffin-embedded sections of human eyes were deparaffinized and rehy-
drated with a graded alcohol series. Immunofluorescent staining was per-
formed with antibodies (Abs) against human vWF (F3520; Sigma), human
macrophagemannose receptor (MMR) (CD206, MAB2534, R&D Systems), hu-
man CD80 (ab53003; Abcam), or human ROCK1 (sc-17794; Santa Cruz
Biotechnology) or ROCK2 (sc-1851; Santa Cruz Biotechnology) and identified
with Alexa Fluor 488 (10mg/ml, A-11055; Invitrogen) or 647 (10mg/ml, A21244;
Invitrogen) secondary Abs. On day 3 after laser injury, 10 mm frozen sections
of the posterior segment were prepared. The mouse eye sections were incu-
bated with a rat antimouse F4/80 mAb (MCA497R, AbD Serotec) or CD11b
(550282, BD PharMingen) and subsequently with the secondary Ab. In monkey
eyes, CD68 (goat pAb, sc-7082; Santa Cruz), vWF (rabbit pAb, A0082; DAKO),
ROCK1 (mouse mAb, sc-17794; Santa Cruz), and ROCK2 (goat pAb, sc-1851;
Santa Cruz) were stained. Images were obtained with a Leica microscope.
Western Blot
To obtain tissues, animals were perfused with PBS, and eyes were enucleated
immediately after perfusion. Choroid-retinal pigment epithelium (RPE) com-
plex were microsurgically isolated and placed in 100 ml of lysis buffer (mamma-
lian cell lysis kit MCL1; Sigma), supplemented with protease and phosphatase
inhibitors (P2850, P5726, P8340; Sigma), and sonicated. The lysatewas centri-
fuged (12,000 rpm, 15 min, 4C), and the supernatant was collected. Each
sample containing an equal amount of total protein, quantified by protein
assay (Bio-Rad Laboratories), was separated by SDS-PAGE and electroblot-
ted to polyvinylidene difluoride (PVDF) membranes (Invitrogen). To block
nonspecific binding, themembraneswere washedwith 5% skimmilk and sub-
sequently incubated with the following: rabbit Abs against phospho-MBS/
MYPT1-THr853 (CY-P1025; Cyclex), MYPT1 (sc-25618; Santa Cruz Biotech-
nology), phospho NF-kB p65 (3033; Cell Signaling), NF-kB p65 (3034; Cell
Signaling), IkB-a (9242; Cell Signaling) or mouse Abs against pIkB-a (9246;
Cell Signaling), ROCK1 and ROCK2 (611136, 610623; BD Transduction Labo-
ratories), phosphorylated ezrin/radixin/moesin (pERM) (3149; Cell Signaling),
ERM (3142; Cell Signaling), phosphorylated myosin light chain (pMLC)
(3675, Cell Signaling), MLC (8505; Cell Signaling), IL-4 (ab11524; Abcam),
CD163 (sc-33560; Santa Cruz Biotechnology), CCR3 (ab32512; Abcam),
CCR7 (ab65851; Abcam), CD80 (ab53003; Abcam), and b-tubulin (ab11308;
Abcam) at 4C overnight, followed by incubation with a horseradish peroxi-
dase-conjugated donkey or sheep Ab against rabbit or mouse IgG (NA934V,
NXA931; GE Healthcare) or goat anti-rat secondary Ab (goat anti-rat IgG-
HRP: sc-2032; Santa Cruz). The signals were visualized by chemilumines-
cence (ECL kit; GE Healthcare).
Real-Time RT-PCR
Total RNA from cultured RAW 264.7 cells was extracted using the RNeasy Plus
Mini Kit (74134; Quiagen); 600 ng cDNA per sample was synthesized with Taq-
Man Reverse Transcription Reagents (N808-0234; Applied Biosystems) using
its contained random hexamers scaled for a reaction volume of 30 ml. Quanti-
tative real-time PCR was performed with the TaqMan Universal PCR Master
Mix (4324018; Applied Biosystems) and the respective probes: CCL22
(Hs00171080_m1; Applied Biosystems), VEGF-A (Mm01281449_m1; TaqMan),
and 18S rRNA (Hs99999901_s1; Applied Biosystems) as endogenous control.
In BMDM experiments, cDNA was synthesized from total RNA with Quanti-
script Reverse Transcriptase and optimized blend of oligo-dT and random
primers (Millipore). Gene expression was measured by the change-in-
threshold (DDCT)method based on quantitative real-time PCR in a Light Cycler
(Roche) with SYBR Green I.
The primer sets for the murine Arg1 (Arginase-1; forward, cctgaaggaact-
gaaaggaaag, reverse, ttggcagatatgcagggagt), Retnla (Fizz1; forward, ccctc
cactgtaacgaagactc, reverse, cacacccagtagcagtcatcc), Chi3l3 (Ym1; forward,
gaacactgagctaaaaactctcctg, reverse, gagaccatggcactgaacg) and Nos2
(iNOS; forward, gggctgtcacggagatca, reverse, ccatgatggtcacattctgc), b-Actin
(Actb; forward, catccgtaaagacctctatgccaac, reverse, accagaggcatacagg
gaca) were used. Experiments were performed using Applied Biosystem’s
Step One Plus real-time PCR system using the company’s standard cycles.
The relative abundance of transcripts was normalized according to that of
mouse GAPDH (4352932; Applied Biosystems), 18S rRNA.
Flow Cytometry
To examine macrophages in the retina and choroid, cells were prepared from
mouse eyes. To collect a sufficient number of ocular infiltrating cells, 50 burns
were delivered to mouse eyes by laser. After laser injury, eyes were enucleated
at different timepoints (1, 2, 3, 5, and 7 days). The anterior segment (cornea, iris,
and lens) was excised, and the posterior segment of the eye, including sclera,
choroid, and retina, was disrupted with scissors and then shaken in DMEM
(plus 10% FBS; GIBCO Laboratories; 100 U/ml penicillin, 100 mg/ml strepto-
mycin) supplementedwith 0.5mg/ml collagenase type D (11088874103; Boeh-
ringer Mannheim) at 37C for 60 min. The supernatants were collected and
passed through a mesh. After three washes, viable cells were obtained. A total
of 12 eyes (six individual pools) was examinedper group. The cells were stained
with PE anti-mouse CD11b (557397; BD PharMingen), FITC anti-mouse CD206
(MMR, 123005; BioLegend), and PE-Cy5 anti-mouse CD80 Abs (15-0801-81;
eBioscience).
RAW 264.7 cells were stained with PerCP anti-mouse CD11b (101230; Bio-
Legend), PerCP anti-mouse F4/80 (123006; BioLegend), PE anti-mouse CD80
(12-0801; eBioscience), and FITC anti-mouse CD206 (141704; BioLegend).
Laser-Induced CNV
Laser-inducedCNV is awound-healingmodel thatmimics the angiogenesis and
leakage aspects of AMD (Ishibashi et al., 1987). To induce CNV, C57BL/6Jmice
were anesthetized, and pupils were dilated with 5% phenylephrine and 0.8%
tropicamide. Using a 532-nm laser (Oculight GLx, Iridex), a slit-lamp delivery
system, and a cover glass as a contact lens, four spots (100 mW, 50 mm,
100 ms) were placed in each eye. The lesions were located at 3, 6, 9, and
12 o’clock meridians centered on the optic nerve head and two to three disk di-
ameters from the optic nerve head. The same technique was used in cynomol-
gus monkeys (700 mW, 100 mm, 100 ms). Development of a bubble under laser
radiation confirmed the rupture of the Bruch’s membrane. Eyes showing hem-
orrhage were excluded from experiments.
Quantification of CNV and Leakage
At 7 or 14 days after laser injury, the size of CNV lesions was measured in
choroidal flat mounts. Briefly, mice were anesthetized and perfused through
the left ventricle with PBS, followed by 5 ml of 5% fluorescein isothiocya-
nate-dextran (FD2000S; Sigma Aldrich) in 1% gelatin. The anterior segment
and retina were removed from the eyecup. The remaining RPE-choroid-sclera
complex was flat mounted, after relaxing radial incisions, using Mounting Me-
dium (FM 100119, Thermo Scientific) and coverslips. Micrographs of the
choroidal complex were taken with a Leica Microscope. The volume of the le-
sions was quantified, using confocal microscopy (Leica TCS SP2 laser scan-
ning confocal microscope). Themagnitude of the CNV lesions was determined
by measuring the hyperfluorescent area with Openlab Software (Improvision).
The grade of leakage was determined by fluorescein angiography (FA).
FA
FA was performed in anesthetized rodents, mice (C57BL/6J) and rats (Brown
Norway), using a digital fundus camera (SLO; HRA2; Heidelberg Engineering) 7
and 14 days after laser injury. Fluorescein injections were performed intrave-
nously (0.2 ml of 2% fluorescein; Akorn, NDC 17478-253-10). For FA in mon-
keys, animals were injected with 5% fluorescein intravenously (Fluorescite,
Alcon). FA images were evaluated by two masked retina specialists. The
grading criteria were grade I, no hyperfluorescence; grade II, hyperfluores-
cence without leakage; grade III, hyperfluorescence in the early or midtransit
images and late leakage; grade IV, bright hyperfluorescence in the transit im-
ages and late leakage beyond the treated areas. The grade IV lesions were
considered clinically significant (Lara-Castillo et al., 2009).
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Treatments
To block both ROCK isoforms, the dual ROCK1/2 inhibitors, fasudil (20mg/kg,
H-2330; LC Laboratories; molecular weight [MW], 364.29) and Y-27632
(10 mg/kg, S1049, http://www.selleckchem.com) were administered daily by
intraperitoneal injections. To block ROCK2, mice received twice daily intraper-
itoneal injections of the selective ROCK2 inhibitor (10 mg/kg, SurfaceLogix,
MW, 570.61). The ROCK2 selective inhibitor, is currently being developed
for clinical use by Kadmon (Kadmon) under the designation KD025. The con-
trol animals received equivalent amounts of vehicle, glyceryl trioctanoate
(91039; Sigma-Aldrich). Intravitreal injections of fasudil and ROCK2 inhibitor
(5 ml in rat and 1 ml in mouse; 30 mmol/l) were performed on days 0, 3, and
6 after CNV induction, using BSS Plus as vehicle. Adult cynomolgus
monkeys received intravitreous injection of fasudil (30 mmol/l) three times per
week.
The inhibitor treatments, unless indicated otherwise, started on day 0 at the
same time as CNV induction and continued daily (fasudil once per day, ROCK2
inhibitor twice per day) until harvest.
Statistical Analysis
All values are expressed as mean ± SEM. Data were analyzed by Student’s t
test, ANOVA, or chi-square test. Differences between the experimental groups
were considered statistically significant (*) or highly significant (**), when the p
was < 0.05 or < 0.01, respectively.
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Supplemental Figure 1,  related to Figure 2:  Structure and nuclear magnetic resonance 
spectra of the ROCK2 inhibitor. (a)  The selective ROCK2 inhibitor, 2-(3-(4-(1H-indazol-5-
ylamino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide (Sweetnam et al., 2010). (b) 1D 1H nuclear 
magnetic resonance (NMR) spectrum, (c) 1D 13C spectrum. (d) double-quantum-filtered correlation 
spectroscopy (COSY), (e) heteronuclear multiple-quantum correlation spectroscopy (HMQC), and (f) 
heteronuclear multiple-bond correlation spectroscopy (HMBC).  The 1D and 2D nuclear magnetic 
resonance (NMR) spectroscopy results matched the properties of the ROCK2 inhibitor.  
The experimental parameters are listed along with the individual spectra, where PULPROG is 
the pulse sequence, TD the size of the FID, NS the number of scan, SWH the spectral width, FIDRES 
the FID resolution, TE the temperature, and D1 the pre-scan delay.  The length of the proton 90o pulse 
was 16 microseconds and that of 13C 10 microseconds.  The spectrometer was a Bruker Avance III 
500 MHz NMR system.  DMSO-d6 was used as a solvent.  To separate overlapping peaks in the 1-D 
1H spectrum, that occasionally occur in 500 MHz NMR instruments, benzene-d6 was added drop-
wise.  Consequently, multiple 1-D and 2-D data sets were collected for structure determination. 
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Supplemental Figure 2, related to Figure 2: Characterization of the ROCK2 inhibitor.  (a) 
The IC50 of the selective ROCK2 inhibitor and the dual ROCK1/2 inhibitor, Y-27632, for ROCK1 and 
ROCK2.  The small molecule ROCK2 inhibitor selectively inhibited ROCK2 (IC50 ~105nM).  In contrast 
to Y-27632 (IC50 111nM), the ROCK2 inhibitor did not affect ROCK1 enzymatic activity at 
concentrations up to 10μM (IC50 24µM).  Briefly, recombinant ROCK1 and ROCK2 enzymes containing 
the truncated catalytic domains (PV3691 and PV3759) were purchased from Invitrogen and enzymatic 
activity was determined using [γ33P]ATP (5µM) and S6 kinase substrate (17µM).  The reaction was run 
for 45min at room temperature and was terminated by the addition of phosphoric acid.  [γ33P] 
phosphorylated S6 peptide was isolated by membrane filtration.  The background was determined by 
running the reaction without enzyme.  Radioactivity was assessed using a Microbeta Jet.  
(b) Comparative enzyme inhibitor kinetics (Ki) of two existing dual ROCK1/2 inhibitors, fasudil 
and Y-27632 (Ishizaki et al., 2000), and the selective ROCK2 inhibitor.  The selective ROCK2 inhibitor 
potently inhibits ROCK2, without affecting ROCK1.  In comparison, Y-27632 and fasudil, showed 
equipotent inhibitory activities against ROCK1 and ROCK2.  Therefore, in this study, the biological 
functions of the ROCK2 inhibitor were compared with the dual ROCK1/2 inhibitors fasudil and 
Y-27632.  
IC50 was determined by curve fitting using GraphPad Prizm software (www.graphpad.com). 
The sigmoidal dose-response (variable slope) equation type analysis was used to generate the IC50 
values.  Ki values were calculated using the Cheng Prusoff equation of Ki = IC50/(1 + [S]/Km), where [S] 
and Km are the concentration of ATP and the Km value of ATP, respectively (Lin et al., 1976).  
Fasudil (HA-1077, 5-(1,4-diazepan-1-ylsulfonyl)isoquinoline hydrochloride, C14H17N3O2S.HCl, 
molecular weight 327.83) is in some countries an approved drug for the human use.  In addition to 
ROCK, fasudil also inhibits, PKA, PKG, PKC, and MLCK with Ki values of 0.33μM, 1.6μM, 1.6μM, 
3.3μM and 36μM, respectively.  
(c)  Pharmacokinetic parameters of the selective ROCK2 inhibitor.   The inhibitor was 
administered orally (po) or intravenously (iv) at the indicated concentrations to mice and the 
pharmacokinetic parameters were calculated from the resulting time versus concentration curves by 
non-compartmental analysis using WinNonlin® (http://www.pharsight.com).  Tmax, time to reach Cmax; 
Cmax, the peak plasma concentration of the inhibitor after administration, AUC, area under the curve; 
t1/2, elimination half time; Vz, volume of distribution; CL, clearance.  Cmax, AUC0-tlast and oral 
bioavailability (%F) of the ROCK2 inhibitor increased in a greater than dose responsive manner when 
the dose of the ROCK2 inhibitor was increased from 20mg/kg to 60mg/kg.  
(d) The selectivity of the ROCK2 inhibitor was tested in the panel of over 220 representative 
enzymes from AGC, CMGC, TK, TKL, STE, CAMK, CK1 kinase families (KinaseProfiler™, Upstate 
Biology/Millipore).  A small number of kinases were partially inhibited by the inhibitor at the measured 
10µM concentration.  IC50 measurements were performed for the kinases susceptible to inhibition by 
the ROCK2 inhibitor (IC50Profiler™, Upstate Biology/Millipore).  Detailed assay description, 
www.millipore.com/techpublications/tech1/pf3036.  ‘h’, human,.  
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Supplemental Figure 3, related to Figure 4d:  Model of leukocyte infiltration in the cornea. 
Schematic of our imaging technique for visualization of transmigrated leukocytes.  By combining the 
growth factor-induced corneal angiogenesis with in vivo acridine orange labeling of leukocytes we 
developed a model, in which the leukocyte extravasation rate from limbal and angiogenic blood 
vessels is visualized and quantified.  
Supplemental Experimental Procedure:  Leukocyte transmigration assay  
To visualize the leukocyte transmigration rate, we used our recently introduced  assay (Nakao 
et al., 2012).  Mice were anesthetized with ketamine (100mg/kg) and xylazine (10mg/kg).  Poly-HEMA 
pellets (0.3µl, P3932; Sigma, St. Louis, MO, USA) containing 400ng MCP-1 (479-JE-010/CF, R&D 
systems) were prepared and implanted into the corneas.  Cytokine pellets were positioned at ~0.8–
1.0mm distance from the corneal limbus.  After implantation, bacitracin ophthalmic ointment (E. 
Fougera & Co., Melville, NY, USA) was applied to each eye to prevent infection.  
To stain the leukocytes, 500µl AO (1mg/ml) was injected intravenously.  Two hours after AO 
injection blood vessels were stained by perfusing the animals with rhodamine-labeled concanavalin A 
lectin (ConA; Vector Laboratories, Burlingame, CA, USA), 10µg/ml in PBS (pH 7.4).  Briefly, under deep 
anesthesia, the chest cavity was opened, and a 24-gauge perfusion needle was placed into the aorta. 
Drainage was achieved by opening the right atrium.  The animals were then perfused with 10ml PBS to 
wash out blood cells in the vessels.  After PBS perfusion, the animals were perfused with 5 ml 
rhodamine-labeled ConA and subsequently with 5ml PBS to remove residual unbound ConA. 
Immediately after perfusion, the corneas were carefully removed, and flatmounts were prepared using 
a mounting medium (TA-030-FM, Mountant Permafluor; Lab Vision).  
Page 3 of 9
Supplemental Figure 4
Zandi et al.
b
F-Actin Paxillin
Control
siRNA
ROCK1
siRNA
ROCK2
siRNA
Dual 
ROCK1/2
siRNA
a DMSO ROCK2 inhibitor Y-27632
No
ne
Bl
oc
klT
Ne
ga
tiv
e 
Co
nt
ro
l
RO
CK
1 
siR
NA
RO
CK
2 
siR
NA
RO
CK
1/
2 
siR
NA
ROCK1
Actin
ROCK2
c
d
Green: Phalloidin 
Red: Paxillin
Blue: DAPI
10nM5nM
Control
Y-27632
10nM5nM
ROCK2 inhibitor
10nM5nM
Fasudil
Supplemental Figure 4, related to Figure 4:  Impact of ROCK inhibition on cytoskletal 
structures.   (a) Cytoskeletal structures of HUVECs treated with the ROCK2 inhibitor or Y-27632 at 
10μM for four hours under normal culture condition.  The cells were stained for actin (green) and 
nucleus (blue) using phalloidin and DAPI, respectively.  ROCK2 inhibition does not affect the 
characteristic cytoskeletal structure, while dual ROCK1/2 inhibition with Y-27632 resulted in an 
atypically uniform cytoskeletal staining.  Scale bar, 20µm. (b) HUVEC cells were stained for the 
cytoskeletal proteins F-actin and paxillin.  ROCK1 blockade diminishes but ROCK2 blockade does not 
affect cytoskeletal structures.  Scale bar, 20µm.  (c) The effect of dual ROCK1/2 or ROCK2 inhibition 
on paxillin distribution was examined in cultured endothelial cells that were inhibitor treated for 30min 
at two different concentrations.  These cells were stained for phalloidin and paxillin.  In the vehicle 
treated controls, paxillin was distributed in the cytoplasm.  When both ROCK isoforms were blocked, 
using the dual ROCK1/2 inhibitors fasudil or Y-27632, paxillin was no longer found evenly spread in 
the cytoplasm.  In these cells paxillin was concentrated in the nuclear or immediate perinuclear 
regions.  In comparison, in the ROCK2 inhibitor treated cells, paxillin distribution in the cells was 
comparable to the control cells.  These results confirm the impact of ROCK isoform knockdowns with 
siRNAs.  More in-depth studies of the cytoskletal changes will be required to understand the individual 
roles of ROCK isoforms in paxillin signaling and focal adhesion kinases.  Scale bar, 20µm.  (d) Western 
analysis of HUVECs transfected with siRNA targeting of ROCK1, ROCK2, or both.  Negative control, a 
scramble 20-mer RNA.  BlockIt (Invitrogen), a fluorescently labeled RNA to track uptake/transfection 
efficiency.  
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Supplemental Figure 5, related to Figure 6:   ROCK signaling in macrophages does not 
affect VEGF-A expression.   VEGF-A is an important growth factor in AMD pathology.  VEGF-A 
inhibition is the current standard in AMD treatment.  To examine the role of ROCK signaling in VEGF-A 
secretion in macrophages, we measured this growth factor in cultured RAW 264.7 monocytes that 
were in M0, M1, and M2 state of differentiation.  (a)  Neither pharmacologic nor (b) gene blockade of 
ROCK isoforms affected VEGF-A gene or protein expression in M0, M1, or M2 macrophages.  These 
data indicate that the anti-angiogenic and anti-leakage properties of ROCK inhibition is unrelated to 
VEGF-A secretion from macrophages.  In line with this finding, our recent clinical data showed that 
ROCK inhibition ameliorates anti-VEGF resistant diabetic macular edema (DME) (Ahmadieh et al., 
2013; Nourinia et al., 2013).  
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Supplemental Figure 6, related to Figure 7a:  Macrophage polarization.   For quality control, 
the M1 and M2 differentiated bone marrow derived macrophages were characterized by flow 
cytometry.  
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Supplemental Figure 7, related to Figure 5b & 7e:  CCR3  expression unchanged in laser-
induced CNV.  CCR3 is a chemokine receptor involved in eosinophil and basophil trafficking.  CCR3 
is also found in TH2 cells (Sallusto et al., 1997) and is thought to take part in the type 2 response 
(Mantovani et al., 2004).  Monocytes express CCR3, albeit at lower levels.  CCR3 was reported to be 
elevated in CNV lesions in human AMD without any involvement of inflammation (Takeda et al., 2009). 
Surprisingly, our results did not show a difference in CCR3 protein expression in CNV compared to 
unlasered normal controls.  Representative western blot from mouse choroidal tissues with and 
without laser injury.  n=3 animals in each group.   
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Supplemental Figure 8, related to Materials and Methods:  Testing for the rd8 in the Crb1 
gene.  The rd8 mutation in the Crb1 gene causes retinal degeneration and AMD like features, which 
was previously erroneously attributed to other causes (Luhmann et al., 2013), i.e. deficiency of the 
Ccl2/Cx3cr1 genes (Ambati et al., 2003).  Several vendor lines are contaminated with the rd8 mutation 
(Mattapallil et al., 2012), which made it necessary to inspect for the mutation in our experimental lines 
for quality control.  For this purpose the PCR method, described by (Mehalow et al., 2003), was used. 
Representative results for each strain in our study is shown, where the size of the WT allele is 220 bp 
and the rd8 allele 244 bp.  The results show that the mice used in our study were WT for the Crb1 
gene.  
Supplemental Experimental Procedure:  Detection of the rd8 mutation by PCR
A fully automated nucleic acid extractor (Magtration System 6GC, PSS Co., Chiba, Japan) with 
a Magtration Genomic DNA Purification Kit (PSS Co.) was used to extract and purify the genomic DNA 
of mouse tail biopsy samples. DNA samples isolated from tail biopsies were amplified separately for 
wild type (WT) allele and mutant rd8 allele using primers specified by (Mehalow et al., 2003).  Primer 
sequences included mCrb1 mF1: GTGAAGACAGCTACAGTTCTGATC; mCrb1 mF2: 
GCCCCTGTTTGCATGGAGGAAACTTGGAAGACAGCTACAGTTCTTCTG; and mCrb1 mR: 
GCCCCATTTGCACACTGATGAC.  The total volume in the individual PCR assays was 40 μl, including 
0.5 μl template DNA, 1.0 µl (10µM) each of forward and reverse primer for WT allele, and 1.0 µl (10µM) 
forward and 0.5 µl (10µM) reverse primer for rd8 mutant allele and 0.2 µl of BIOTAQTM HS DNA 
polymerase (BIOLINE), and 20 µl of 2×Ampdirect®  Plus (Shimadzu Corp, Kyoto, Japan) containing 
MgCl2 (3mM) and dNTPs (400µM each). Reactions initially were denatured at 94℃ for 5 minutes 
followed by 35 cycles at 94℃ for 30 seconds, 65℃ for 30 seconds, 72℃ for 30 seconds and a final 
extension at 72℃ for 7 minutes. Amplicons were separated using 3% agarose gel and visualized 
under UV light after staining with ethidiumbromide. Amplicon sizes are WT allele=220 bp and rd8 
allele=244 bp.  
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